D-66447-001 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

Recall Details

Product Type
Drugs
Report Date
November 13, 2013
Initiation Date
September 23, 2013
Termination Date
April 5, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9020 vials

Product Description

Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA, NDC 0143-9702-01.

Reason for Recall

Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.

Distribution Pattern

Nationwide

Code Information

Lot #: AC0020, Exp 03/14; AC0023, AC0025, Exp 08/14